Skip to content

A feasibility study of WATCH IT: a community intervention to reduce morbidity in obese children

A feasibility study of WATCH IT: a community intervention to reduce morbidity in obese children - a randomised controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN95431788
Enrollment
70
Registered
2007-08-08
Start date
2006-10-01
Completion date
Unknown
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

The intervention is a community based programme to tackle obesity through one-to-one and group sessions. The control group is a 12 month wait list control.

Sponsors

University of Leeds (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Young people aged 8 - 15 years with a BMI (Body Mass Index) above the 98th centile are eligible provided they and their principal carer have fluent English.

Exclusion criteria

Exclusion criteria: 1. Siblings of enrolled participants 2. Learning difficulties to a degree that precludes grasping the cognitivve component of the programme 3. Recent initiation of obesity reduction medication (for example, orlisat, metformin and sibutramine) 4. Young people with a medical cause for obesity or a psychiatric morbidity

Design outcomes

Secondary

MeasureTime frame
Secondary outcomes of adiposity will be obtained from bioimpedance, BMI SD score and waist circumference at 6 and 12 months. Other secondary outcomes relate to feasibility (e.g. recruitment rate, attrition, acceptability etc.) plus, biomedical markers of morbidity, lifestyle, psycholoigal measures and physical fitness.

Primary

MeasureTime frame
The primary outcome is adiposity at 12 months. This will be assessed using % body fat by Dual Energy X-ray Absorptiometry (DEXA) scan, which will also provide more detailed outcomes relating to body fat: namely total and % fat mass, and total and % lean tissue, given as overall measures and broken down by region (abdomen, trunk, legs, arms).

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026